Wagphar Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 25-05-2024
- Paid Up Capital ₹ 0.60 M
as on 25-05-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 25-05-2024
- Revenue 4869836.07%
(FY 2022)
- Profit 267.03%
(FY 2022)
- Ebitda -16362.07%
(FY 2022)
- Net Worth 6.54%
(FY 2022)
- Total Assets 775.43%
(FY 2022)
About Wagphar Biotech
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹1.00 M.
Rajeev Kumar and Amit Kumar serve as directors at the Company.
- CIN/LLPIN
U24299HR2021PTC092321
- Company No.
092321
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Yamuna Nagar, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Wagphar Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Kumar  | Director | 19-Jan-2021 | Current |
| Amit Kumar | Director | 19-May-2021 | Current |
Financial Performance and Corporate Structure Insights of Wagphar Biotech.
Wagphar Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 4869836.07% increase. The company also saw a substantial improvement in profitability, with a 267.03% increase in profit. The company's net worth moved up by a moderate rise of 6.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wagphar Biotech?
Unlock access to Wagphar Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Altrawell Biotech Private Limited
Active 4 years 4 monthsRajeev Kumar and Amit Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Feb 2022 | ₹1.00 M | Open |
How Many Employees Work at Wagphar Biotech?
Wagphar Biotech has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wagphar Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wagphar Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
